The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL).
ALL
IFN-γ
IL-6
Journal
Pathology oncology research : POR
ISSN: 1532-2807
Titre abrégé: Pathol Oncol Res
Pays: Switzerland
ID NLM: 9706087
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
25
01
2018
accepted:
01
11
2018
pubmed:
18
11
2018
medline:
14
1
2021
entrez:
17
11
2018
Statut:
ppublish
Résumé
Interferon gamma (IFN-γ) and interleukin 6 (IL-6) are including the most important cytokines which have been associated with the biological behavioral and immune responses in malignancies. Based on the critical roles which these two cytokines play against tumor cells, the present study was aimed to investigate the genes expression level of IL6 and IFN-γ in patients with Acute Lymphoblastic Leukemia and compare with normal controls. Fifty-two patients with ALL and 13 healthy volunteer were under studied. The peripheral blood mononuclear cells of all patients and normal controls were separated by ficoll. The expression of interferon gamma and interleukin 6 genes were determined by RQ-PCR. Finally all data were analyzes using T student, one way ANOVA and Mann-Whitney tests were use to analyze all samples data. Our finding showed that the level of IFN-γ gene expression was significant decreased in patients with All as compared with healthy controls (83 change fold, p < 0.0001). The level of IL-6 Gene expression was not changeable in B-ALL patients as compared with healthy control (p = 0.4), but in T-ALL patients, was significantly reduced (p < 0.01). The results of present study indicated that IFN-γ gene expression reduced in ALL patients. It provides a valuable insight that immune system may disrupted in patients with ALL, which cause tumor cells escape from immune surveillance.
Identifiants
pubmed: 30443842
doi: 10.1007/s12253-018-0536-z
pii: 10.1007/s12253-018-0536-z
doi:
Substances chimiques
IL6 protein, human
0
Interleukin-6
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
461-466Références
Eur J Cancer. 2008 May;44(7):937-45
pubmed: 18387296
Braz J Med Biol Res. 2008 May;41(5):344-50
pubmed: 18488097
Leuk Res. 2011 Feb;35(2):275-7
pubmed: 20943267
Cancer. 2005 Mar 1;103(5):1054-63
pubmed: 15651075
Cytokine. 2013 Mar;61(3):885-91
pubmed: 23357299
Am J Obstet Gynecol. 2004 Nov;191(5):1598-605
pubmed: 15547530
Haematologia (Budap). 1998;29(2):101-14
pubmed: 9728802
Biochem Pharmacol. 2009 Sep 1;78(5):514-22
pubmed: 19433065
Int J Paediatr Dent. 2012 May;22(3):191-6
pubmed: 21919984
Leuk Lymphoma. 1996 Mar;21(1-2):49-52
pubmed: 8907269
Biochem J. 2003 Aug 15;374(Pt 1):1-20
pubmed: 12773095
Zhonghua Nei Ke Za Zhi. 1993 Feb;32(2):85-7
pubmed: 8404330
Zhongguo Dang Dai Er Ke Za Zhi. 2006 Dec;8(6):461-3
pubmed: 17178034
Blood. 2007 Mar 1;109(5):2008-13
pubmed: 17068155
Blood. 1992 Apr 15;79(8):2076-83
pubmed: 1562733
Hematology Am Soc Hematol Educ Program. 2013;2013:118-25
pubmed: 24319172
J Immunol. 2006 Jun 15;176(12):7686-94
pubmed: 16751416
Ann Clin Lab Sci. 2006 Winter;36(1):7-15
pubmed: 16501231
Sci Rep. 2015 Jun 22;5:11394
pubmed: 26096712
Adv Cancer Res. 1986;46:1-265
pubmed: 2425561
Cancer Immunol Immunother. 2000 Jun;49(3):165-72
pubmed: 10881696